Please login to the form below

Not currently logged in
Email:
Password:

Emerging Companies

This page shows the latest Emerging Companies news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate

Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate

In some cases, this has seen originator companies matching prices of biosimilar entrants in order to hold onto their market share. ... Beigene is part of a wave of new China-based biotech companies who are emerging rapidly thanks to new rules in Hong

Latest news

  • Smart solutions Smart solutions

    As pharmaceutical manufacturers face the threats of generic competition and increasing payer pressure, technology-enabled solutions are emerging as a smart way for companies to add genuine value and extend the ... also feeling the heat and companies are

  • Fair to medalling Fair to medalling

    There needs to be a greater focus on emerging environments and better contingency planning. “ ... However, many plans don't adequately account for emerging risks. Companies need mechanisms in place to monitor and respond to external drivers so they can

  • Astellas launches digital health investment company Astellas launches digital health investment company

    DigiTx Partners aims to identify and foster those companies that will meaningfully contribute to this improvement. ... With digital health of increasing interest to pharma a number of companies have set up 'accelerator' programmes to support emerging

  • Prices of AZ and GSK drugs slashed in China Prices of AZ and GSK drugs slashed in China

    The price reductions are a blow to companies hoping to expand in emerging markets such as China, with prospects already dented by the downturn in the global economy, pricing pressure on ... Both GSK and AZ have previously suggested that emerging markets

  • Pfizer signs $900m-plus deal with WAVE for metabolic R&D Pfizer signs $900m-plus deal with WAVE for metabolic R&D

    Commenting on the deal, Morris Birnbaum, chief scientific officer at Pfizer's cardiovascular and metabolic research unit, said: "By working together to develop unique proprietary technologies emerging from both companies, we

More from news
Approximately 0 fully matching, plus 58 partially matching documents found.

Latest Intelligence

  • Dispensing with the past Dispensing with the past

    Current board composition at the top pharma companies shows that on average 22% of board directors have some operational experience in emerging markets. ... Just under half (40%) of top pharma companies have three or more board directors with operational

  • Healthcare costs Healthcare costs

    The healthcare industry is being disrupted - new business models and strategies are emerging and companies are stepping up to take their place in the new landscape.”. ... For pharmaceutical companies, the ability to develop more effective drugs through

  • Adapting to the digital consumer Adapting to the digital consumer

    Based on the expected outcome, companies need to decide where to be present and build the required capabilities. ... There are also new types of businesses emerging. Companies such as LifeQ, which uses computational systems biology to provide consumers

  • Choosing wisely Choosing wisely

    Choosing wisely. How to make the best of emerging markets. The notion that pharmaceutical companies are pondering which emerging markets they should target is slightly disingenuous. ... The whole concept of emerging markets is dubious,” says Mark

  • Anticipating the future in healthcare Anticipating the future in healthcare

    Budget pressure and emerging markets:The slowing of GDP growth in established markets and continued budget pressure have led international healthcare companies to search for opportunities in emerging markets. ... Digital transformation:Digital health

More from intelligence
Approximately 2 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Training the next generation of biotech leaders

    This skills shortage is a major challenge for the sector. Currently, the number of biotech companies emerging is growing much faster than the talent pool. ... society. “ We look at the manufacturing challenges we are facing for emerging healthcare

  • ONYX Scientific

    ONYX Scientific. We are a contract manufacturing pharma organisation (CMO) chemistry contract research organisation (chemistry CRO) that provides pharmaceutical chemistry services to large and emerging pharm biotech companies across the globe,

  • HAVAS LYNX

    In recent decades, emerging technologies have repeatedly forced smart companies to answer the question: what’ s new here and what’ s our strategy now? ... Today, smart pharma companies should be asking that same question about another major

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics